ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

On-and-off fasting helps fight obesity, study finds

Can Pomegranates Slow Aging?

Calorie restriction promotes longevity through effects on mitochondrial network

Discover Why Ashwagandha Can Be Used for Stress and Anxiety

Lower magnesium levels linked with increased mortality risk during up to 40 years of follow-up

A spoonful of oil: Fats and oils help to unlock full nutritional benefits of veggies, study suggests

Higher resveratrol dose linked to lower glucose levels in type 2 diabetics

How Can You Benefit From Vitamin B12?

Drug can dramatically reduce weight of people with obesity

What Is Bitter Orange?

 
Print Page
Email Article

Parkinsonianlike Signs Linked to Development of Alzheimer's Disease

  [ 41 votes ]   [ Discuss This Article ]
www.ProHealth.com • May 5, 2003


An increase in motor problems like those seen in Parkinson's disease is associated with the development of Alzheimer's disease in old age, according to a study in the April issue of The Archives of Neurology.

According to the study, signs similar to those seen in people with Parkinson's disease (PD), including irregular gait, rigidity, tremor and limited movement, are common in older people without AD, and the presence of these signs may be linked to the development of AD. However, the progression and severity of these signs and subsequent development of AD has not been studied.

Robert S. Wilson, PhD, and colleagues of Rush-Presbyterian-St. Luke’s Medical Center studied the association of the progression of parkinsonianlike signs with the development of AD and cognitive decline. The researchers studied 824 older Catholic clergy members (average age at the beginning of the study was 75.4 years) without any clinical evidence of AD or PD at the beginning of the study. The participants had annual clinical exams and completed a modified version of the Unified Parkinson’s Disease Rating Scale (UPDRS, a test that measures signs of PD), detailed cognitive testing and testing for signs of AD. Participants were followed up for an average of 4.6 years, with some studied for up to 8 years.

The researchers found that over the average follow up time of 4.6 years, 114 participants developed AD. The UPDRS scores increased (indicating a worsening of parkinsonianlike symptoms) in 79 percent of participants, who were divided into groups with the least, moderate or most rapid progression. The researchers found that compared with the 21 percent without progression, the risk of AD more than doubled in the subgroup with the least progression, more than tripled in the moderate subgroup, and increased more than 8-fold in the subgroup with the most rapid progression.

The researchers report that the effect was mostly due to worsening gait and rigidity. They also found that rate of change on the UPDRS measure was inversely associated with the rate of change on tests measuring cognitive function.

The researchers conclude: "In a cohort of more than 700 older persons examined annually for up to 8 years, evidence of parkinsonianlike signs at baseline, as assessed on the UPDRS, was associated with increased risk of incident AD. After controlling for baseline UPDRS, annual rate of progression on the UPDRS was related to disease incidence. Compared with those without progression on the UPDRS, risk of developing AD was increased more than 8-fold in those with the most rapid progression. The results suggest that progression of parkinsonianlike signs in older persons is related to the development of AD."



Post a Comment

Featured Products From the ProHealth Store
FibroSleep™ Energy NADH™ 12.5mg Ultra EPA  - Fish Oil


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength

Natural Remedies

Strengthen Cell Function with Energy-Boosting Niagen Strengthen Cell Function with Energy-Boosting Niagen
Everything You Always Wanted to Know About Sleep But Were Too Tired to Ask Everything You Always Wanted to Know About Sleep But Were Too Tired to Ask
Pioneer Scientists Uncover a Revolutionary Neuroprotective Supplement for Nerve Health Pioneer Scientists Uncover a Revolutionary Neuroprotective Supplement for Nerve Health
How I Found My Long-Lost Energy How I Found My Long-Lost Energy
The Cellular Enzyme That Promotes Longevity And Reduces Fat Storage The Cellular Enzyme That Promotes Longevity And Reduces Fat Storage

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map